Skip to search formSkip to main contentSkip to account menu

wobe-mugos E

Known as: Wobe-Mugos, wobe mugos E 
An enzymatic preparation containing proteolytic enzymes papain, trypsin and chymotrypsin with potential anti-inflammatory and anticarcinogenic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
[Effects of proteolytic enzyme therapy with Wobe Mugos against chemotherapy-induced toxicity in breast cancer patients - results of a pilot study].
BACKGROUND Wobe Mugos(®) is an enzyme preparation containing the proteases trypsin and papain from the pancreatic calf and… 
2010
2010
Proteolytische Enzymtherapie mit Wobe Mugos® gegen Chemotherapie-bedingte Toxizitäten bei Brustkrebs-Patientinnen – Ergebnisse einer Pilotstudie
SummaryBACKGROUND: Wobe Mugos® is an enzyme preparation containing the proteases trypsin and papain from the pancreatic calf and… 
2006
2006
Micronuclei evaluation of reduction in neoadjuvant chemotherapy related acute toxicity in locally advanced lung cancer: an indian experience.
BACKGROUND Lung cancer is the most common cancer in the world accounting for 17.6% cancers worldwide. The AAR i n I ndian… 
2001
2001
[Use of WOBE-MUGOS E for prevention and correction of experimental doxorubicin side-effects].
Examined in treating rats with Guerin's carcinoma with doxorubicin was the possibility that the polyenzymic drug preparation wobe… 
2000
2000
[The effect of the preparation Wobe-Mugos E on the functional and biochemical status of the kidneys in the polyuric stage of sublimate-induced nephropathy].
The protective effect of Wobe-Mugos appliance on the kidney function and biochemical state in polyuric stage of sublimate… 
1999
1999
Effect of an enzyme complex upon the immune system studied on the streptomycin model of suppressed digestion
As is known, diseases of the digestive organs are accompanied by changes in the functional properties of all chains in the immune… 
1998
1998
[The use of enzymes in treating patients with malignant lymphoma with a large tumor mass].
Systemic enzymes (wobenzime and wobe-mugos) were approved, that had been prescribed as part of polychemotherapy to 24 patients… 
1995
1995
[Modification of liver parameters by adjuvant administration of proteolytic enzymes following chemotherapy in patients with ovarian carcinoma].
In a single-blind placebo controlled trial with 3 parallel groups the effects of concomitant administration of proteolytic… 
Review
1991
Review
1991
[Acute circulatory shock following administration of the non-regular enzyme preparation Wobe-Mugos].
: A 54-year-old female patient was treated by a homoeopathic physician with non-orthodox enzyme therapy because of complaints… 
Review
1989
Review
1989
Circulating antibodies to mouse monoclonal immunoglobulins caused false-positive results in a two-site assay for alpha-fetoprotein.
Previously we reported on a patient who underwent an adjuvant chemotherapy because of spuriously increased alpha-fetoprotein (AFP… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)